CERE – cerevel therapeutics holdings, inc. (US:NASDAQ)
Stock Stats
News
NASDAQ CERE INVESTIGATION ALERT Leading Law Firm BFA LLP Notifies CERE Shareholders of Investigation into the Cerevel Therapeutics Merger with AbbVie Contact Firm for More Information
CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough? Bleichmar Fonti & Auld LLP is Currently Investigating the Acquisition
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson's Disease Treatments [Yahoo! Finance]
BUYOUT INVESTIGATION ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) and Encourages Investors to Contact the Firm
CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) Buyout and Encourages Investors to Contact the Firm
Form 4 Cerevel Therapeutics For: May 10 Filed by: COLES N ANTHONY
Form 144 Cerevel Therapeutics Filed by: COLES N ANTHONY
Form SC 13G/A Cerevel Therapeutics Filed by: FMR LLC
Form 10-Q Cerevel Therapeutics For: Mar 31
Form 10-K/A Cerevel Therapeutics For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.